This report was first published by Endpoints News. To see the original version, click here
Eli Lilly needs to do a better job of explaining its deal with the Trump Administration over making its blockbuster weight loss drugs more affordable, Sen. Ruben Gallego (D-AZ) wrote in a letter on Tuesday to Eli Lilly CEO David Ricks.
While the deal may prove significant for those looking to lose weight on these drugs, Gallego notes that so far, “the public has been provided with only sparse details” about the deal, how it will work with the incoming price negotiations under the Inflation Reduction Act, or how it allows Lilly to avoid tariffs.
您已閱讀100%（639字），剩余0%（1字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。